• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Biocon launches Tacrolimus capsules in US

expresspharmaDecember 29, 2020

Tag: Biocon , Tacrolimus Capsules , US , immunosuppressant , Organ transplant

Biocon announced the launch of Tacrolimus capsules in the US. Tacrolimus, a calcineurin inhibitor, is an immunosuppressant used in the treatment of organ transplant patients, which reduces the body’s ability to reject a transplanted organ.

It has been particularly effective in treating patients of renal transplant for more than two decades.

Siddharth Mittal, CEO and MD, Biocon, said, “The launch of Tacrolimus capsules in the US is another milestone for Biocon that reflects our commitment to continually evaluate and expand our portfolio of complex products to serve patients.”


Previous:LYNPARZA (olaparib) get three new approvals in Japan

Next:Serum Institute of India launches indigenously developed pneumococcal vaccine, ‘PNEUMOSIL’

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Biocon launches Tacrolimus capsules in US | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Industrial scale freeze dryer

Industrial scale freeze dryer
ALFBC-25 Continuous Horizontal Cartoner

ALFBC-25 Continuous Horizontal Cartoner
Imipenem and cilastatin sodium with sodium bicarbonate USP

Imipenem and cilastatin sodium with sodium bicarbonate USP
Natural Cas 9072-19-9 Fucoxanthin Seaweed Fucus Vesiculosus Powder Gagome Kelp Extract Fucoidan

Natural Cas 9072-19-9 Fucoxanthin Seaweed Fucus Vesiculosus Powder Gagome Kelp Extract Fucoidan
EP8; USP38, 99% up by HPLC Spironolactone 52-01-7

EP8; USP38, 99% up by HPLC Spironolactone 52-01-7
Deturiumlamp- Deuterium lamp HERAEUS lamp

Deturiumlamp- Deuterium lamp HERAEUS lamp
amber glass bottle,various size

amber glass bottle,various size
High purity Eucalyptus Oil,Cas 8000-48-4

High purity Eucalyptus Oil,Cas 8000-48-4
Argatroban anhydrous

Argatroban anhydrous
High quality Marasmius androsaceus,Polysaccharides 30%

High quality Marasmius androsaceus,Polysaccharides 30%

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service